Cargando…
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
Autores principales: | Lyski, Zoe L., Kim, Sunny, Lee, David Xthona, Sampson, David, Raué, Hans P., Raghunathan, Vikram, Ryan, Debbie, Brunton, Amanda E., Slifka, Mark K., Messer, William B., Spurgeon, Stephen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437317/ https://www.ncbi.nlm.nih.gov/pubmed/34518841 http://dx.doi.org/10.1101/2021.09.02.21262146 |
Ejemplares similares
-
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia
por: Lyski, Zoe L., et al.
Publicado: (2022) -
Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
por: Lyski, Zoe L., et al.
Publicado: (2022) -
Vaccinations in CLL: implications for COVID-19
por: Shadman, Mazyar, et al.
Publicado: (2021) -
Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
por: Hsieh, Yuli Lily, et al.
Publicado: (2022) -
Pfizer: The miracle vaccine for COVID-19?
por: Badiani, A.A., et al.
Publicado: (2020)